Medications not yet evaluated by P&T are considered NON-FORMULARY . . . . . Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step! . . . . . Please be sure to document all clinical activities daily.
Search results for:

revefenacin

revefenacin
  • Non-formulary
  • Therapeutic Interchange
Drug Name Form Strength Formulary Unrestricted Formulary Restricted Non-Formulary Interchange
Yupelri SOLUTION, INHALATION 175 mcg/3 mL    
Comments:

Yupelri medication guide

Ordered Formulation Therapeutic Interchange

revefenacin (Yupelri)

  • 175 mcg inhalation neb once daily

ipratropium (Atrovent)

  • 0.5 mg inhalation neb q6 hrs, maximum 4 treatments per day

Reviewed: 25 June 19 (Yupelri)

Last updated: Jun. 26, 2019






This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.

Copyright © 2024 Rpharmy, LLC ­ All Rights Reserved